Wealthfront Advisers’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$266K Buy
10,048
+1,289
+15% +$34.2K ﹤0.01% 890
2025
Q1
$212K Buy
8,759
+3,786
+76% +$91.4K ﹤0.01% 904
2024
Q4
$200K Buy
+4,973
New +$200K ﹤0.01% 895